Tools hub
Financial Calculators
Private, in-browser — no account required.
Recent
quick returnPopular searches
live pathsNasdaqGS · Healthcare
$205.10
▲ +$0.0100(+0.00%)4:00 PM ET - vs previous closeiQuote as of Jul 31, 2026, 4:00 PM EDT
NasdaqGS market is closed. Showing the latest available regular-session trade from Jul 31, 2026, 4:00 PM EDT.
Market data source
Chart
Latest 1D session
1Y · weekly bars · USD · Live $205.10 · 254 pts
Live checkTrade access
Affiliate disclosure: TECHi may earn a commission on links to broker partners. Read more.
Investor playbook
The current snapshot gives bulls more to work with, but the watch list still controls timing.
Use it for
Entry timing, risk check, and catalyst scan
What has to keep working for US investors to stay interested.
Trend support
+46.8%Current price is above the 200-day average.
Catalysts and positioning checks that are not duplicate live-pulse metrics.
Latest catalyst
YahooWhy Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Outlook On Clinical Sequencing
The playbook is derived from quote, analyst, financial, news, and trend snapshots. It is a research workflow aid, not a buy or sell recommendation.
As of Jul 31, 2026, 4:00 PM EDT, Illumina Inc (ILMN) traded at $205.10, a +0.00% move versus the prior close, ranging between $192.84 and $205.93 intraday, and on volume of 4.1M shares. The stock has traded between $88.00 and $205.93 over the past 52 weeks, carries a market capitalization of $31.03B, and trades at 38.34x trailing earnings. Sell-side analysts rate ILMN Buy across 28 ratings and carry an average price target of $193.05 (-5.87% implied versus the last quote). ILMN's record close stands at $540.63, set on Feb 12, 2021.
Buy analyst tone. Latest catalyst: Why Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Outlook On Clinical Sequencing (Yahoo).
Balanced watch. Track record validation (76/100) is the strongest signal; valuation pressure (42/100) is the main constraint. Model confidence is 34/100 — some inputs are unavailable, so treat this as a directional research screen rather than a forecast. Long-term secular context is tracked separately: 1 Year +99.7% total; yesterday 0%. Comparable past signals have verified against subsequent prices 9.8% of the time.
Expected-return math is scaled by beta and realized volatility before confidence is applied.
Short-horizon expected moves are volume-weighted so thin moves get less credit than confirmed tape.
Sector momentum is included beside the broader market regime.
| Price / sales | 6.91 |
| Price / book | 10.93 |
| Operating margin | 19.65% |
| Return on assets | 12.41% |
| EPS (TTM) | $5.35 |
| Beta (5Y) | 1.46 |
Benchmark context
Compare against its sector ETF and the broad market.
Help · FAQ
4 answers covering latest price, analyst view, and sector context.
TECHi displays provider-supplied values only when the corresponding field is present.
TECHi.com